Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | 6.56% | 74.70 | 1.0% | $1317.97m | |
| BIIB | Biogen, Inc. | 1.03% | 327.45 | 1.5% | $652.73m | |
| AMGN | Amgen, Inc. | 1.98% | 214.54 | 1.3% | $528.56m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 3.52% | 457.92 | 2.6% | $493.97m | |
| ILMN | Illumina, Inc. | 1.76% | 274.70 | 3.5% | $395.63m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.89% | 232.04 | 1.9% | $340.69m | |
| MRNA | Moderna, Inc. | 22.73% | 29.16 | 0.0% | $244.82m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.42% | 94.78 | 2.0% | $216.14m | |
| A | Agilent Technologies, Inc. | 0.22% | 78.12 | 1.6% | $163.65m | |
| EXAS | EXACT Sciences Corp. | -6.67% | 80.76 | 24.0% | $139.73m | |
| INCY | Incyte Corp. | 0.84% | 77.97 | 2.5% | $113.49m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.24% | 91.22 | 4.3% | $106.57m | |
| SGEN | Seattle Genetics, Inc. | -0.24% | 112.11 | 6.1% | $105.02m | |
| CODX | Co-Diagnostics, Inc. | 106.26% | 8.90 | 0.0% | $96.40m | |
| XLRN | Acceleron Pharma, Inc. | -0.94% | 87.36 | 6.1% | $84.00m |
Company Profile
At Achillion, we are driven to transform the lives of patients and families affected by diseases of the complement system, an integral part of the innate immune system. Scientific and clinical evidence has implicated the complement system, and specifically the complement Alternative Pathway (AP), in numerous devastating diseases and conditions. Our principal focus at Achillion is to advance our clinical-stage portfolio of orally administered factor D inhibitors into late-stage development and potential commercialization for patients with devastating disorders of the complement system.